RECCE LTD.
Recce Pharmaceuticals (ASX:RCE) is a world leader in synthetic polymer-antibiotics. The Company is developing a new class of broad spectrum antibiotics targeting superbugs.
RECCE LTD.
Industry:
Biotechnology Pharmaceutical
Founded:
2008-01-01
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.recce.com.au
Total Employee:
1+
Status:
Active
Contact:
+61 (2) 8075 4585
Email Addresses:
[email protected]
Total Funding:
28 M AUD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
4D Pharma
4D Pharma PLC is a world leader in the development of live biotherapeutics.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Current Employees Featured
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-12 | Recce Pharmaceuticals Appoints Philip Sutton, Ph.D., as Vice President of Translational Sciences |
Official Site Inspections
http://www.recce.com.au Semrush global rank: 2.44 M Semrush visits lastest month: 7.35 K
- Host name: lamp6.cloudservers.net.au
- IP address: 103.9.64.186
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
More informations about "Recce Ltd."
RCE Corporate Presentation - Recce
This presentation has been prepared by Recce Pharmaceuticals Ltd (the “Company”). It does not purport to contain all the information that a prospective investor may require in connection with …See details»
RCE Corporate Presentation - recce.com.au
About Recce Pharmaceuticals Ltd *Awarded by the US FDA in 2017 for R327 bacteraemia (broad-spectrum bacterial sepsis). Time starts only from potential market approval. 2 Recce …See details»
ASX:RCE - 2024 Annual General Meeting - investorhub.recce.com.au
Read and interact with this announcement: 2024 Annual General Meeting on Recce Pharmaceuticals's investor hubSee details»
Recce Pharmaceuticals Ltd - LinkedIn
Recce Pharmaceuticals Ltd (ASX: RCE, FSE:R9Q) is pioneering the development and commercialisation of a new class of synthetic antibiotics with broad spectrum activity designed …See details»
Home | Recce Pharmaceuticals investor hub
View share price, top shareholders, your shareholding, and interact with announcements for Recce Pharmaceuticals.See details»
ASX:RCE - Annual Report to Shareholders - investorhub.recce.com.au
Read and interact with this announcement: Annual Report to Shareholders on Recce Pharmaceuticals's investor hubSee details»
Recce Pharmaceuticals Ltd - MTPConnect
Recce Pharmaceuticals (ASX: RCE, FSE: R9Q) is pioneering New Classes of Synthetic Anti-Infectives designed to address the urgent global health threat posed by antibiotic resistant …See details»
RCE News, Analysis, Announcements & Results | Recce …
6 days ago · The latest Recce Pharmaceuticals Ltd [RCE] news, articles, data and analysis from The Australian Financial ReviewSee details»
Recce Pharmaceuticals secures Australian patent for synthetic anti ...
1 day ago · Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) CEO James Graham joins Proactive’s Tylah Tully to discuss the latest milestone of being granted an Australian patent for …See details»
Recce Pharmaceuticals Announces Addition of RECCE® 327 to The …
Inclusion underscores significance of RECCE® 327 (R327) in combating antimicrobial resistance and its potential to treat broad range of life-threatening and resistant bacteria.See details»
Recce Pharmaceuticals Announces Addition of RECCE® 327
Jun 20, 2024 · Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health problems of antibiotic …See details»
Recce Pharmaceuticals Granted Australia Patent for RECCE®
1 day ago · Recce Pharmaceuticals Ltd +61 (02) 9256 2571 [email protected]. Media & Investor Relations (AU) Andrew Geddes Seed Media +61 (02) 9267 4511 …See details»
Recce Pharmaceuticals Management - Simply Wall St
Nov 6, 2024 · Learn about Recce Pharmaceuticals Ltd (RCE) stock's management team. Comprehensive performance, salary and tenure analysis for the CEO, board and leadership …See details»
Corporate Governance | Recce Pharmaceuticals
Recce Pharmaceuticals (ASX: RCE) and its Board of Directors prioritise effective, transparent, and ethical governance for efficient organizational management.See details»
Recce Pharmaceuticals Ltd (RCE) Stock Price & News - Google
Get the latest Recce Pharmaceuticals Ltd (RCE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.See details»
Recce Pharmaceuticals Granted Australia Patent for RECCE® Anti ...
1 day ago · SYDNEY, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q), the Company developing a new class of synthetic anti-infectives, today …See details»
RCE Corporate Presentation - recce.com.au
This presentation has been prepared by Recce Pharmaceuticals Ltd (the “Company”). It does not purport to contain all the information that a prospective investor may require in connection with …See details»
Recce: From No More Tears to no more superbug fears
Oct 22, 2024 · More than 100 people have now been dosed with R327, showing promise in solving the growing resistance of deadly bacteria to antibiotics. It has undergone Phase-2 trials …See details»
ASX:RCE - Annual Report to shareholders - Recce
Read and interact with this announcement: Annual Report to shareholders on Recce Pharmaceuticals's investor hubSee details»
Le stress thermique environnemental dans l’espèce bovine : 1 ...
6 days ago · Le stress thermique se définit comme l’état de déséquilibre entre, d’une part, les facteurs qui contribuent à augmenter la température corporelle et d’autre part, ceux qui au …See details»